Latest News

The partnership will equip hospitals and healthcare providers with cutting-edge, high-quality interventional cardiac solutions designed to meet the growing demand for advanced cardiovascular care.

The Lassa Fever E2E Access Roadmap establishes a comprehensive, regionally driven approach that connects every critical stage in transitioning a vaccine from development to sustained, widespread use.

The partnership builds on a Memorandum of Collaboration signed last year under the Global Oncology Initiative, which set the foundation for comprehensive cancer management improvements at the regional referral facility.

The deal centers on one of SanegeneBio’s innovative RNAi programs and grants Genentech exclusive worldwide rights to develop and bring the treatment to market.

The new Irish facility aims to accelerate innovation and bring next-generation diagnostic capabilities to hospitals and laboratories worldwide.

The divestment positions Halo to focus on expanding into more complex drug-product manufacturing services while strengthening its presence in the sterile CDMO market.

The acquisition encompasses MDCO’s complete portfolio of ophthalmic devices, including intraocular lenses (IOL), implantable contact lenses (Phakic Lens), and various refractive device platforms.

Rather than applying the same treatment blueprint to every patient, the team now maps each patient’s unique brainwave patterns before deciding where to place electrodes and how to deliver electrical pulses.

Umniya evolved directly from HealthPlus IVF, a practice that had already earned years of trust among patients in Abu Dhabi.

Unlike traditional bypass surgery, which relies on a heart-lung machine, the off-pump approach allows surgeons to operate while the patient’s heart continues to beat naturally.